Market Chatter: US Set to Impose 100% Tariffs on Some Drug Imports

MT Newswires Live04-02

The US is set to impose 100% tariffs on certain imported medicines as part of an attempt to pressure pharmaceutical firms to shift production to the US, the Financial Times reported Thursday, citing people familiar with the matter.

The levies, which are set to be announced Thursday, apply to imports from companies and countries that have yet to strike deals with the White House, the report said.

The European Union, the UK, Pfizer (PFE), AstraZeneca (AZN), and Novo Nordisk (NVO) are among those that have worked out deals for lower tariffs, the report said.

The White House did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment